SHG · Healthcare

Shanghai Haohai Biological Tech Co (688366)

Biotechnology

Shanghai Haohai Biological Tech Co (688366) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $8.87B, P/E ratio is 36.34, net margin is 10.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 688366

Market cap
$8.87B
P/E ratio
36.34
Gross profit (TTM)
$1.73B
Net margin
10.2%

Shanghai Haohai Biological Tech Co (688366) — FAQ

What is Shanghai Haohai Biological Tech Co's market cap?

Shanghai Haohai Biological Tech Co (688366) has a reported market cap of $8.87B (data as of 2026-03-29).

What is 688366's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Haohai Biological Tech Co (688366) is 36.34 (data as of 2026-03-29).

Does Shanghai Haohai Biological Tech Co pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Haohai Biological Tech Co (688366). Check the MyAverix Finance app for the latest dividend data.

What sector is Shanghai Haohai Biological Tech Co in?

Shanghai Haohai Biological Tech Co (688366) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 688366 listed on?

688366 is listed on SHG.

What is Shanghai Haohai Biological Tech Co's net margin?

Shanghai Haohai Biological Tech Co (688366) reports a net margin of 10.2% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play